Hello pharma – this is becoming more and more unavoidable. Payers are strongly leaning towards value-based contracting. This article, published October 26, 2016 on www.healthcaredive.com, reinforces the trend. The article also points out the barrier we have so often discussed – how to access the patient data and how to do so within a tightly regulated market. Here is the link to the original article – http://www.healthcaredive.com/news/how-payers-are-tackling-value-based-drug-pricing/429015/.
The holy grail:
“What society is saying with value-based pricing is that if you produce a drug with huge health benefits, we are willing to pay a lot to incentivize the development of these types of treatments,” Shafrin said.
We, at Inspired Health Strategies, believe we have a solution to help document patient value via patient reported outcomes through RememberitNow, a therapeutically agnostic, fully patient customizable platform and app. RememberitNow collects patient reported outcomes and whatever data the user desires. The patient can share with whomever they want, ensuring a greater continuity of care. And, certainly, RememberitNow can act as a person’s personal health record – finally, a system truly universal and patient-centered.The sponsor will get at least aggregate data to indicate not only drug performance but also the all important lifestyle and behavioral indicators hat play a huge role is ensuring better health management.
Click here to see how we can help you prepare for values-based contracting – https://inspiredhealthstrategies.com/28751-2/